Risk of lower limb amputation in diabetic patients using SGLT2 inhibitors versus DPP4 inhibitors or GLP-1 agonists: a meta-analysis of 2 million patients

BACKGROUND: The objective of this review was to assess the risk of lower limb amputation (LLA) in type 2 diabetic patients based on the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) versus dipeptidyl peptidase 4 inhibitors (DPP4i) or glucagon-like peptide-1 receptor agonists (GLP1a). MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yang, Guo, Caiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272677/
https://www.ncbi.nlm.nih.gov/pubmed/37332886
http://dx.doi.org/10.1177/20420986231178126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272677/
https://www.ncbi.nlm.nih.gov/pubmed/37332886
http://dx.doi.org/10.1177/20420986231178126

Ejemplares similares